atenolol has been researched along with Angiokeratoma in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Angiokeratoma: A vascular, horny neoplasm of the skin characterized by TELANGIECTASIS and secondary epithelial changes including acanthosis and hyperkeratosis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gandhi, R | 1 |
| Ganatra, B | 1 |
| Kelly, A | 1 |
| Natkunarajah, J | 1 |
1 other study available for atenolol and Angiokeratoma
| Article | Year |
|---|---|
Treatment of eruptive angiokeratomas of the flanks with topical and oral beta-blockers.
Topics: Abdomen; Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Angiokeratoma; | 2021 |